In breast carcinoma patients, a low CMG2 mRNA expression was also correlated with a worsened overall survival rate (relative risk RR = 1.35, see Figure 4 a); however, this result showed only a trend towards significance.
← all excerpts
CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.
1
—
—